Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has updated the status of the Tabelecleucel study for EBV+ PTLD from 'Active, not recruiting' to 'Completed' and has changed the relevant dates to reflect this update.SummaryDifference0.5%
- Check23 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions of a clinical study on tabelecleucel for treating EBV+ PTLD, while adding a new version number and a brief mention of the study's purpose. The name of the study and the study director's name have also been altered.SummaryDifference30%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has updated the status of the Tabelecleucel study for EBV+ PTLD from 'Active, not recruiting' to 'Completed', and the relevant dates have been changed to reflect this update.SummaryDifference0.8%
Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.